PML
VAXX

Prime Movers Lab’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Prime Movers Lab’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,603,276
Closed -$31.4M – 9
2022
Q3 		$31.4M Sell
17,603,276
-245,038
-1% -$510K 22.58% 4
2022
Q2 		$25.2M Sell
17,848,314
-179,000
-1% -$677K 13.43% 4
2022
Q1 		$69.8M Hold
18,027,314
– – 19.45% 4
2021
Q4 		$91M Buy
+18,027,314
New +$186M 17.39% 3

Other funds holding VAXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prime Movers Lab's VAXX Position: Q4 2022 in Review

Prime Movers Lab sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2022, closing a stake of 17,603,276 shares — an estimated $31.4M sold.

Prime Movers Lab first reported a position in VAXX in Q4 2021 and held it in 4 quarters. The position peaked at $91M in Q4 2021. 30 funds tracked by Wall St. Rank hold VAXX as of Q4 2022.

  • Prime Movers Lab reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Prime Movers Lab sold 17,603,276 Vaxxinity, Inc. Class A Common Stock shares in Q4 2022, an estimated $31.4M.
  • Prime Movers Lab first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • Prime Movers Lab's Vaxxinity, Inc. Class A Common Stock position peaked at $91M in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2022.

Based on Prime Movers Lab's 13F filing for Q4 2022, filed 14 Feb 2023.